Literature DB >> 18036801

Omega-3 fatty acids and neurological injury.

Adina T Michael-Titus1.   

Abstract

Studies with omega-3 polyunsaturated fatty acids (PUFA) have shown that these compounds have therapeutic potential in several indications in neurology and psychiatry. Acute spinal cord injury (SCI) is an event with devastating consequences, and no satisfactory treatment is available at present. The pathogenetic mechanisms associated with SCI include excitotoxicity, increased oxidation and inflammation. We review here our recent studies, which suggest that omega-3 PUFA have significant neuroprotective potential in spinal cord trauma. In a first study, we administered an intravenous bolus of alpha-linolenic acid (LNA) or docosahexaenoic acid (DHA) 30 min after spinal cord hemisection injury in adult rats. The omega-3 PUFA led to increased neuronal and glial survival, and a significantly improved neurological outcome. In subsequent studies, we tested DHA in a more severe compression model of SCI. We also explored a combined acute and chronic treatment regime using DHA. Saline or DHA was administered intravenously 30 min after compression of the spinal cord. After injury, the saline group received a standard control diet, whereas DHA-injected animals received either a control or a DHA-enriched diet for 6 weeks following injury. We assessed locomotor recovery and analysed markers for cell survival and axonal damage, and we also investigated the effects of the treatment on the inflammatory reaction and the oxidative stress that follow SCI. We showed that the acute DHA treatment is neuroprotective after compression SCI, even if the treatment is delayed up to an hour after injury. The DHA injection led to an increased neuronal and glial cell survival, and the effect of the DHA injection was amplified by addition of DHA to the diet. Rats treated with a DHA injection and a DHA-enriched diet performed significantly better at 6 weeks in terms of neurological outcome. The analysis of the tissue after DHA administration showed that the fatty acid significantly reduced lipid peroxidation, protein oxidation and RNA/DNA oxidation, and the induction of COX-2. Parallel studies in a facial nerve injury model in mice also showed pro-regenerative effects of chronic dietary administration of DHA after nerve lesion. These observations suggest that treatment with omega-3 PUFA could represent a promising therapeutic approach in the management of neurological injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036801     DOI: 10.1016/j.plefa.2007.10.021

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  15 in total

Review 1.  Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.

Authors:  Jessay Gopuran Devassy; Shan Leng; Melissa Gabbs; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

2.  Docosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic inflammation.

Authors:  Deborah R Berman; Yi Qing Liu; John Barks; Ellen Mozurkewich
Journal:  Am J Obstet Gynecol       Date:  2010-03-31       Impact factor: 8.661

Review 3.  Oxidative stress and antioxidative parameters in patients with spinal cord injury: implications in the pathogenesis of disease.

Authors:  G Fatima; V P Sharma; S K Das; A A Mahdi
Journal:  Spinal Cord       Date:  2014-11-04       Impact factor: 2.772

4.  The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.

Authors:  Ozlem Ozsoy; Gamze Tanriover; Narin Derin; Nimet Uysal; Necdet Demir; Burcu Gemici; Ceren Kencebay; Piraye Yargicoglu; Aysel Agar; Mutay Aslan
Journal:  Neurotox Res       Date:  2011-01-14       Impact factor: 3.911

Review 5.  Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury.

Authors:  Brandon P Lucke-Wold; Aric F Logsdon; Linda Nguyen; Ahmed Eltanahay; Ryan C Turner; Patrick Bonasso; Chelsea Knotts; Adam Moeck; Joseph C Maroon; Julian E Bailes; Charles L Rosen
Journal:  Nutr Neurosci       Date:  2016-10-05       Impact factor: 4.994

Review 6.  Neuroinflammatory pathways in binge alcohol-induced neuronal degeneration: oxidative stress cascade involving aquaporin, brain edema, and phospholipase A2 activation.

Authors:  Michael A Collins; Edward J Neafsey
Journal:  Neurotox Res       Date:  2011-09-17       Impact factor: 3.911

7.  Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  P A Dacks; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2013-03       Impact factor: 4.075

Review 8.  The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling.

Authors:  Karen Wagner; Steve Vito; Bora Inceoglu; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-09-18       Impact factor: 3.072

9.  Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia.

Authors:  Deborah R Berman; Ellen Mozurkewich; Yiqing Liu; John Barks
Journal:  Am J Obstet Gynecol       Date:  2009-03       Impact factor: 8.661

10.  Dietary Omega-3 Fatty Acids Do Not Change Resistance of Rat Brain or Liver Mitochondria to Ca(2+) and/or Prooxidants.

Authors:  Irina G Stavrovskaya; Susan S Bird; Vasant R Marur; Sergei V Baranov; Heather K Greenberg; Caryn L Porter; Bruce S Kristal
Journal:  J Lipids       Date:  2012-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.